PLATINUM INVESTMENT MANAGEMENT LTD
Position in ARVN — Arvinas, Inc.
CIK 1256071
SYDNEY AUSTRALIA 2000, C3
Position in ARVN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$768,786
-$91,384 QoQ
Shares Held
72,527
0.0% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PLATINUM INVESTMENT MANAGEMENT LTD holds $78,056,040 across 25 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
58,314 | $7,740,017 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
154,220 | $5,968,314 | |
| 3 | IMVT |
Immunovant, Inc.
|
144,671 | $5,574,173 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
64,752 | $5,277,935 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
138,708 | $5,169,647 | |
| 6 | VERA |
Vera Therapeutics, Inc.
|
113,687 | $4,878,309 | |
| 7 | GPCR |
Structure Therapeutics Inc.
|
90,363 | $4,849,782 | |
| 8 | RCUS |
Arcus Biosciences, Inc.
|
134,217 | $4,137,910 |
All Filings in ARVN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $768,786 | 72,527 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $860,170 | 72,527 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $740,643 | 86,930 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||